Effect of stimulation of natural killer cells with an anti-CD137 mAb on the efficacy of trastuzumab, cetuximab, and rituximab.
Holbrook Edwin Kohrt
No relevant relationships to disclose
Roch Houot
No relevant relationships to disclose
Kipp Weiskopf
No relevant relationships to disclose
Matthew Goldstein
No relevant relationships to disclose
Peder Lund
No relevant relationships to disclose
Ferenc Scheeren
No relevant relationships to disclose
Debra Czerwinski
No relevant relationships to disclose
A. Dimitrios Colevas
No relevant relationships to disclose
Wen-Kai Weng
No relevant relationships to disclose
Michael F. Clarke
No relevant relationships to disclose
Robert W. Carlson
No relevant relationships to disclose
John Sunwoo
No relevant relationships to disclose
Thomas Tedder
No relevant relationships to disclose
Lieping Chen
No relevant relationships to disclose
Ronald Levy
No relevant relationships to disclose